We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
Cap. Flow
-$18.1M
Cap. Flow %
-12.5%
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$269K
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$197K
3
MO icon
Altria Group
MO
+$144K
4
MPT
Medical Properties Trust
MPT
+$127K
5
XOM icon
ExxonMobil
XOM
+$117K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$582K
2
MPC icon
Marathon Petroleum
MPC
+$200K
3
AER icon
AerCap
AER
+$196K
4
XPO icon
XPO
XPO
+$195K
5
CPB icon
Campbell Soup
CPB
+$186K

Sector Composition

Rank Sector Weight
1 Technology 16.31%
2 Healthcare 10.05%
3 Consumer Staples 8.95%
4 Communication Services 7.78%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FEO
651
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
– –
-750
Closed -$10K
RADA
652
DELISTED
Rada Electronic Industries Ltd
RADA
– –
-711
Closed -$3K
TWTR
653
DELISTED
Twitter, Inc.
TWTR
– –
-836
Closed -$34K
GBT
654
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-925
Closed -$45K
RDUS
655
DELISTED
Radius Health, Inc.
RDUS
– –
-791
Closed -$20K
NPTN
656
DELISTED
NEOPHOTONICS CORP
NPTN
– –
-1,857
Closed -$11K
COHR
657
DELISTED
Coherent Inc
COHR
– –
-91
Closed -$14K
CALA
658
DELISTED
Calithera Biosciences, Inc
CALA
– –
-73
Closed -$4K
ATRS
659
DELISTED
Antares Pharma, Inc.
ATRS
– –
-2,099
Closed -$7K
ZNGA
660
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-628
Closed -$4K
DISCK
661
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
– –
-2,300
Closed -$57K
INFO
662
DELISTED
IHS Markit Ltd. Common Shares
INFO
– –
-810
Closed -$54K
RDS.B
663
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
– –
-1,112
Closed -$67K
ATH
664
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
– –
-1,027
Closed -$43K
LMRK
665
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
– –
-2,271
Closed -$41K
ADMS
666
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-313
Closed -$2K
CLDR
667
DELISTED
Cloudera, Inc.
CLDR
– –
-3,517
Closed -$31K
PFPT
668
DELISTED
Proofpoint, Inc.
PFPT
– –
-41
Closed -$5K
QTS
669
DELISTED
QTS REALTY TRUST, INC.
QTS
– –
-539
Closed -$28K
USCR
670
DELISTED
U S Concrete, Inc.
USCR
– –
-255
Closed -$14K
TLND
671
DELISTED
Talend S.A. American Depositary Shares
TLND
– –
-571
Closed -$19K
LMNX
672
DELISTED
Luminex Corp
LMNX
– –
-1,120
Closed -$23K
GRUB
673
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
– –
-533
Closed -$60K
FLIR
674
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
– –
-1,250
Closed -$66K
AT
675
DELISTED
Atlantic Power Corporation
AT
– –
-300
Closed -$1K
25 26
27
28 29

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.

  • Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
  • Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
  • Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
  • Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
  • Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
  • Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
  • Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.